John Strain bought $119k of LESLQ
director at Leslie's, Inc.. 150,000 shares at an average of $0.79, traded May 13, 2025, filed May 14, 2025.
Score components
- +15RoleDirector
- +10Trade size$118k at market
- +10Relative to holdingsHoldings up 125%
- 0Price contextNo price history yet
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-071365, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 13, 2025 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: By Trust | +150,000 | $0.79 | $119k | 270,000 | May 14, 2025 |
Related signals
Other insiders at Leslie's, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 47Moderate | Leslie's, Inc. | Anthony A Iskander See Remarks | $50k 63,995 shares | +3200% | |
| 45Moderate | Leslie's, Inc. | Susan C OFarrell director | $25k 31,500 shares | +71% | |
| 36Weak | Leslie's, Inc. | Maile Naylor director | $9,960 12,000 shares | +42% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.